MSF says Trump's refugee ban puts Syrian lives at risk
U. S. President Donald Trump's decision to stop resettlement of Syrian refugees will cost lives, medical charity Medecins Sans Frontieres (MSF) said on Monday.
Following is a summary of current health news briefs.
MSF says Trump's refugee ban puts Syrian lives at risk
U.S. President Donald Trump's decision to stop resettlement of Syrian refugees will cost lives, medical charity Medecins Sans Frontieres (MSF) said on Monday. "The president's executive order will effectively keep people trapped in war zones, directly endangering their lives," MSF, also known as Doctors Without Borders, said in a statement.
Dutch commit $10 million to replace lost U.S. abortion funding
The Netherlands has committed $10 million for an initiative to replace funding for abortion services in developing countries that will be lost due to U.S. President Donald Trump's ban on financing foreign groups that provide abortions. Trump reinstated a policy on Monday requiring overseas organizations that receive U.S. family-planning funds to certify they do not perform abortions or provide abortion advice as a method of family planning.
Danish drugmaker Novo Nordisk bets $145 million on post-Brexit UK science
Novo Nordisk, the world's top maker of diabetes drugs, is investing 115 million pounds ($145 million) in a new research centre in Britain, undeterred by Brexit. The Danish company said on Monday it would invest the money over 10 years in the centre based at the University of Oxford, which will employ 100 scientists hunting for new ways to treat type 2 diabetes.
Europe faces steep price increases for some old cancer drugs
European prices for some off-patent cancer drugs have risen by more than 100 percent in the past five years, with two cases of hikes exceeding 1,000 percent, according to data presented at a medical conference on Saturday. Similar price rises for old drugs have sparked outrage in the United States, where former hedge fund manager Martin Shkreli was pilloried in 2015 for increasing the cost of an anti-parasitic medicine by more than 5,000 percent.
(This article has not been edited by DNA's editorial team and is auto-generated from an agency feed.)
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
)
){kind=small}
){kind=small}
)
)
)
)
)
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}